ArticlesRegulatory October 5, 2024 2024 Global Biopharma Sustainability Review CytivaThis report is based on data from 800 pharma and biopharma professionals at director-level and… Ross Burns
ArticlesRegulatory February 9, 2024 Paring Down Impurities in Downstream Processing Myriad choices confront manufacturers before they even consider optimizing downstream processes. admin-element
ArticlesRegulatory December 1, 2023 Getting your investigational drug regulatory ready Navigating regulatory requirements can be an overwhelming and time-consuming part of the translational... admin-element
ArticlesRegulatory August 25, 2023 A risk based approach to sterile filtration Drug quality cannot be assured only by finished-product testing. Process validation is required to... admin-element
ArticlesRegulatory June 13, 2023 Simulation gets therapies to patients faster and smarter Digital solutions are helping to decrease therapeutic time to market but remain challenging – learn… admin-element
ArticlesRegulatory June 2, 2023 The Smart Benefit of Digital Systems in Preclinical Studies The advancement of smart drug development reaches far back in the drug development cycle, starting… admin-element
ArticlesRegulatory January 26, 2023 How Well Do You Know Process Development? HTPD. DoE. Process understanding. Check your mastery of these and other essential terms by taking... admin-element
ArticlesRegulatory June 2, 2022 e-Learning: what is quality by design (QbD)? This free interactive course shares what quality by design (QbD) is all about. The focus… admin-element
ArticlesDownstreamRegulatoryUpstream March 25, 2021 Basics in Process Development for Biotherapeutics Definitions, activities, and things to consider when developing an upstream or downstream bioprocess. admin-element
ArticlesBioPharmaDownstreamRegulatoryUpstream July 2, 2019 Addressing the Complex Nature of Downstream Processing with QbD Regulators have been encouraging bio/pharmaceutical companies to incorporate the concept of... admin-element